polyneuropathy associated with IgM monoclonal gammapathy with anti-MAG | ClinicalTrials HQ

View definition

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study Evaluating the Predictive Value of the Terminal Latency Index (TLI) for Treatment Response in Patients With Anti-MAG Neuropathy	nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy associated with IgM monoclonal gammapathy with anti-MAG	Not yet recruiting	Not stated	2026-08-31		NCT07794137
Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP	Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease type 1A, Charcot-Marie-Tooth disease type 4B2, Charcot-Marie-Tooth disease type 4D, Chronic Disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, central nervous system malformation, chronic inflammatory demyelinating polyradiculoneuropathy, demyelinating disease, hereditary disease, hereditary motor and sensory neuropathy, immune system disorder, inherited neurodegenerative disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyneuropathy associated with IgM monoclonal gammapathy with anti-MAG, polyradiculoneuropathy	Recruiting	Not stated	2026-03-10		NCT07461896
Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders	polyneuropathy associated with IgM monoclonal gammapathy with anti-MAG	Recruiting	Phase 3	2025-11-24		NCT05136976